Company intelligence / Profile preview

Drug Rediscovery Group

Ownership: Private
Development stage: Phase 3

Overview

DRG focuses on identifying and developing novel treatment opportunities from established drugs through real-world clinical discoveries and medical research

Therapeutic areas: OncologyOphthalmology
Modalities: Small molecules
Industry: Biotech

Drug pipeline

2 assets

sildenafil

Phase 3

Indications: Erectile dysfunction, Pulmonary arterial hypertension

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Drug Rediscovery Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drug Rediscovery Group.

Explore the full profile